A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom

INTRODUCTION: Neovascular age-related macular degeneration (nAMD) is the leading cause of vision loss among persons aged 65 years and older. Anti-vascular endothelial growth factor (anti-VEGF) treatment is the recommended standard of care. The current study compares the effectiveness of ranibizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Robert L., Carius, Hans-Joachim, Skelly, Adrian, Ferreira, Alberto, Milnes, Fran, Mitchell, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350206/
https://www.ncbi.nlm.nih.gov/pubmed/28144918
http://dx.doi.org/10.1007/s12325-017-0483-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350206/
https://www.ncbi.nlm.nih.gov/pubmed/28144918
http://dx.doi.org/10.1007/s12325-017-0483-1

Ejemplares similares